Location History:
- Chicago, IL (US) (2002)
- Hummelstown, PA (US) (1999 - 2015)
Company Filing History:
4 out of 1,218 
1 out of 1 
1 out of 4,770 
Years Active: 1999-2015
Title: Craig M Meyers: Innovator in Oncolytic Virus Research
Introduction
Craig M Meyers is a prominent inventor based in Hummelstown, PA (US). He has made significant contributions to the field of cancer research, particularly through his innovative work with parvoviruses. With a total of 7 patents, Meyers has established himself as a key figure in the development of oncolytic virus therapies.
Latest Patents
Meyers' latest patents focus on the use of parvoviruses, specifically the adeno-associated virus Type 2 (AAV2), for targeting neoplastic cells. His inventions demonstrate that AAV2 can selectively induce apoptosis in cancer cells while sparing healthy cells. One of his notable patents describes a method for killing cancer and other neoplastic cells by administering AAV2 proteins, such as Rep78 or Rep68, or pharmaceutical compositions containing these proteins. Another patent outlines a similar approach, emphasizing the use of AAV2 virus, viral particles, or replication-incompetent vectors to effectively target and eliminate cancerous cells.
Career Highlights
Throughout his career, Craig M Meyers has worked with the Penn State Research Foundation, where he has furthered his research in oncolytic viruses. His work has garnered attention for its potential to revolutionize cancer treatment through innovative viral therapies.
Collaborations
Meyers has collaborated with notable colleagues, including Samina Alam and Laimonis A Laimins, contributing to the advancement of research in his field.
Conclusion
Craig M Meyers is a distinguished inventor whose work in oncolytic virus research has the potential to change the landscape of cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.